Stock BMY BRISTOL-MYERS SQUIBB COMPANY
Add to a list
To use this feature you must be a member
Log inSign up
ChatBot Beta

Share ownership Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 04:00:02 2025-02-11 pm EST 		After market 04:24:02 pm
55.94 USD +0.74% Intraday chart for Bristol-Myers Squibb Company 56.13 +0.34%
Feb. 10 Daiwa Securities Adjusts Bristol-Myers Squibb Price Target to $60 From $65, Maintains Outperform Rating MT
Feb. 10 Bristol Myers Squibb Sees Positive Results for Breyanzi in Lymphoma Trials DJ

Share class: Bristol-Myers Squibb Company

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A12,923,176,6742,025,788,374 ( 69.3 %) 895,000,000 ( 30.62 %) 69.3 %

Major shareholders: Bristol-Myers Squibb Company

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.298 %
188,571,307 9.298 % 11 116 M $
BlackRock Advisors LLC
5.685 %
115,294,804 5.685 % 6 797 M $
State Street Corp.
4.58 %
92,896,580 4.58 % 5 476 M $
JPMorgan Investment Management, Inc.
3.842 %
77,930,051 3.842 % 4 594 M $
Charles Schwab Investment Management, Inc.
2.973 %
60,300,475 2.973 % 3 555 M $
Fidelity Management & Research Co. LLC
2.212 %
44,864,347 2.212 % 2 645 M $
Geode Capital Management LLC
2.13 %
43,204,016 2.13 % 2 547 M $
Capital Research & Management Co. (International Investors)
2.103 %
42,647,759 2.103 % 2 514 M $
BlackRock Life Ltd.
1.842 %
37,367,033 1.842 % 2 203 M $
Norges Bank (13F)
1.607 %
32,594,416 1.607 % 1 921 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
NameEquities%Valuation
Mercer Global Investments Europe Ltd.
0.01 %
203,425 0.01 % 12 M $
BRAM - Bradesco Asset Management SA DTVM
0.000228 %
4,631 0.000228 % 275 117 $
NameEquities%Valuation
Transcend Capital Advisors LLC
-
117,775 - 4 829 $
FourWorld Capital Management LLC
-
100,000 - 4 100 $
Davenport & Co. LLC
-
83,970 - 3 443 $
Purkiss Capital Advisors LLC
-
26,450 - 1 084 $
Fifth Third Bancorp
-
20,000 - 820 $
Watts Gwilliam & Co. LLC
-
20,000 - 820 $
Two Sigma Securities LLC
-
15,771 - 647 $
Private Advisor Group LLC
-
15,000 - 615 $
Trivium Point Advisory LLC
-
10,000 - 410 $
Northwestern Mutual Wealth Management Co.
-
341 - 14 $
░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional61.3%
Other8.87%
State Street Corp.4.58%
Schweizerische Nationalbank0.28%
Sumitomo Mitsui Trust Group, Inc.0.23%
Swedbank AB0.16%
Governments0.14%
Manulife Financial Corp.0.08%
SEI Investments Co.0.08%
Individuals0.07%
Skandinaviska Enskilda Banken AB0.07%
Fifth Third Bancorp0.04%
Banco Bilbao Vizcaya Argentaria SA0.03%
Old Republic International Corp.0.03%
Pinnacle Financial Partners, Inc.0.02%
Hancock Whitney Corp.0.02%
The Bank of Nova Scotia0.02%
Corebridge Financial, Inc.0.02%
Peapack-Gladstone Financial Corp.0.02%
ING Groep NV0.02%
Banque Cantonale Vaudoise0.01%
Kinsale Capital Group, Inc.0.01%
Silvercrest Asset Management Group, Inc.0.01%
Associated Banc-Corp0.01%
California First Leasing Corp.0.01%
AlTi Global, Inc.0.01%
Zions Bancorporation NA0.01%
Regions Financial Corp.0.01%
Cadence Bank0.01%
Sumitomo Mitsui Financial Group, Inc.0.01%
Unknown23.82%

Based on 1000 largest holdings

Geographical origin of shareholders

United States 57.64%
United Kingdom 8.59%
Norway 1.89%
Canada 1.88%
Switzerland 1.01%
Australia 0.85%
Sweden 0.67%
France 0.54%
Japan 0.42%
South Korea 0.41%
Netherlands 0.33%
Denmark 0.33%
Germany 0.31%
Belgium 0.24%
Hong Kong 0.24%
Ireland 0.19%
Luxembourg 0.12%
Finland 0.1%
Spain 0.08%
Italy 0.08%
Individuals 0.07%
Austria 0.06%
Taiwan 0.06%
Czech Republic 0.02%
Singapore 0.01%
Liechtenstein 0.01%
India 0.01%
New Zealand 0.01%
South Africa 0.01%
Slovenia 0.01%
China 0.01%

Based on 1000 largest holdings

Company Profile

Logo Bristol-Myers Squibb Company
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.
Employees
34,100
Sector
Pharmaceuticals
Calendar
2025-04-24 - Q1 2025 Earnings Release
More about the company
  1. Stock Market
  2. Equities
  3. BMY Stock
  4. Company Bristol-Myers Squibb Company
  5. Share ownership